<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>3408</number>
    <updateDate>2019-11-15T21:57:55Z</updateDate>
    <updateDateIncludingText>2019-11-15T21:57:55Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2008-07-31</introducedDate>
    <congress>110</congress>
    <committees>
      <item>
        <systemCode>ssfi00</systemCode>
        <name>Finance Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2008-08-01T02:03:55Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2008-07-31</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S7961-7966)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2008-07-31</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S7960-7961)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-31</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>B000243</bioguideId>
        <fullName>Sen. Baucus, Max [D-MT]</fullName>
        <firstName>MAX</firstName>
        <lastName>BAUCUS</lastName>
        <party>D</party>
        <state>MT</state>
        <middleName>SIEBEN</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>C000705</bioguideId>
        <fullName>Sen. Conrad, Kent [D-ND]</fullName>
        <firstName>KENT</firstName>
        <lastName>CONRAD</lastName>
        <party>D</party>
        <state>ND</state>
        <sponsorshipDate>2008-07-31</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B000468</bioguideId>
        <fullName>Sen. Bingaman, Jeff [D-NM]</fullName>
        <firstName>JESSE</firstName>
        <lastName>BINGAMAN</lastName>
        <party>D</party>
        <state>NM</state>
        <middleName>FRANCIS</middleName>
        <sponsorshipDate>2008-09-10</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000802</bioguideId>
        <fullName>Sen. Whitehouse, Sheldon [D-RI]</fullName>
        <firstName>Sheldon</firstName>
        <lastName>Whitehouse</lastName>
        <party>D</party>
        <state>RI</state>
        <sponsorshipDate>2008-09-10</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Accident insurance</name>
        </item>
        <item>
          <name>Auditing</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional investigations</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>Economics and Public Finance</name>
        </item>
        <item>
          <name>Evaluation research (Social action programs)</name>
        </item>
        <item>
          <name>Finance and Financial Sector</name>
        </item>
        <item>
          <name>Government trust funds</name>
        </item>
        <item>
          <name>Health insurance</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>Medical statistics</name>
        </item>
        <item>
          <name>Medical technology</name>
        </item>
        <item>
          <name>Medicare</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Social Welfare</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2008-07-31</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2008-10-21T15:23:35Z</updateDate>
        <text><![CDATA[ <p>Comparative Effectiveness Research Act of 2008 - Amends title XI (General Provisions, Peer Review, and Administrative Simplification) of the Social Security Act to provide for a program of comparative effectiveness research for health care. Defines &quot;comparative effectiveness research&quot; as research evaluating and comparing the implications and outcomes of two or more health care strategies to address a particular medical condition. </p><p>Establishes the Health Care Comparative Effectiveness Research Institute as a nonprofit, nongovernmental, corporation to conduct research on the effectiveness of health care treatments, including pharmaceuticals, medical devices and procedures, and other therapies. Requires the Institute to: (1) identify national priorities for comparative clinical effectiveness research; (2) establish and update a research project agenda and provide for peer review of research; (3) collect data on health care treatments; (4) establish a standing methodology committee for developing the science of comparative effectiveness research; and (5) disseminate research findings.</p><p>Amends the Internal Revenue Code to establish in the Treasury the Comparative Effectiveness Research Trust Fund. Provides revenues for the Trust Fund by transferring amounts from the General Fund and the Medicare Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds and by imposing a fee on certain accident or health insurance policies and self-insured health plans. Requires the Comptroller General to review financial audits of the Institute and assess the adequacy and use of funding. Terminates all funding for the Trust Fund after FY2018.</p><p>Requires the Comptroller General to report to Congress on the process for making national coverage determinations under the Medicare program.</p>]]></text>
      </summary>
    </summaries>
    <title>Comparative Effectiveness Research Act of 2008</title>
    <titles>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Comparative Effectiveness Research Act of 2008</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>Comparative Effectiveness Research Act of 2008</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes.</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2008-07-31T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110s3408is/xml/BILLS-110s3408is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2008-07-31</actionDate>
      <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S7961-7966)</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
